These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 27252267)
1. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies. Bentow C; Rosenblum R; Correia P; Karayev E; Karayev D; Williams D; Kulczycka J; Fritzler MJ; Mahler M Lupus; 2016 Jul; 25(8):897-904. PubMed ID: 27252267 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of anti-DFS70 antibodies in patients with and without systemic autoimmune rheumatic diseases. Shovman O; Gilburd B; Chayat C; Amital H; Langevitz P; Watad A; Guy A; Perez D; Azoulay D; Blank M; Segal Y; Bentow C; Mahler M; Shoenfeld Y Clin Exp Rheumatol; 2018; 36(1):121-126. PubMed ID: 28770702 [TBL] [Abstract][Full Text] [Related]
3. Application of anti-DFS70 antibody and specific autoantibody test algorithms to patients with the dense fine speckled pattern on HEp-2 cells. Lee H; Kim Y; Han K; Oh EJ Scand J Rheumatol; 2016; 45(2):122-8. PubMed ID: 26643611 [TBL] [Abstract][Full Text] [Related]
4. A better definition of the anti-DFS70 antibody screening by IIF methods. Infantino M; Shovman O; Pérez D; Grossi V; Manfredi M; Benucci M; Damiani A; Gilburd B; Azoulay D; Serrano A; Shoenfeld Y J Immunol Methods; 2018 Oct; 461():110-116. PubMed ID: 30017652 [TBL] [Abstract][Full Text] [Related]
5. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262 [TBL] [Abstract][Full Text] [Related]
6. [Investigation of the diagnostic value of anti-dense fine speckled 70/lens epithelium derived growth factor p75 autoantibody for autoimmune diseases]. Türkoğlu G; Berkem R; Karakoç AE Mikrobiyol Bul; 2018 Oct; 52(4):413-424. PubMed ID: 30522426 [TBL] [Abstract][Full Text] [Related]
7. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Mahler M; Hanly JG; Fritzler MJ Autoimmun Rev; 2012 Jul; 11(9):642-5. PubMed ID: 22100330 [TBL] [Abstract][Full Text] [Related]
8. Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence. Bizzaro N; Tonutti E; Tampoia M; Infantino M; Cucchiaro F; Pesente F; Morozzi G; Fabris M; Villalta D; Clin Chim Acta; 2015 Dec; 451(Pt B):271-7. PubMed ID: 26471835 [TBL] [Abstract][Full Text] [Related]
9. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort. Miyara M; Albesa R; Charuel JL; El Amri M; Fritzler MJ; Ghillani-Dalbin P; Amoura Z; Musset L; Mahler M Clin Dev Immunol; 2013; 2013():703759. PubMed ID: 23476678 [TBL] [Abstract][Full Text] [Related]
10. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings. Bonroy C; Schouwers S; Berth M; Stubbe M; Piette Y; Hoffman I; Devreese K; Van Hoovels L Clin Chem Lab Med; 2018 Jun; 56(7):1090-1099. PubMed ID: 29427547 [TBL] [Abstract][Full Text] [Related]
11. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies. La Jeon Y; Kang SY; Lee WI; Kim MH Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339 [TBL] [Abstract][Full Text] [Related]
12. Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey. Bentow C; Fritzler MJ; Mummert E; Mahler M Auto Immun Highlights; 2016 Dec; 7(1):8. PubMed ID: 27395414 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of anti-DFS70 autoantibodies in a Latin American cohort of patients with systemic lupus erythematosus and without autoimmune diseases. Aragón CC; Posso-Osorio I; Puerta G; González JD; Naranjo JC; Echeverri A; Ortíz E; Nieto-Aristizábal I; Barrera MC; Ríos-Serna LJ; Tobón GJ Clin Rheumatol; 2020 Jul; 39(7):2163-2169. PubMed ID: 32086623 [TBL] [Abstract][Full Text] [Related]
14. The Clinical Relevance of Anti-DFS70 Autoantibodies. Conrad K; Röber N; Andrade LE; Mahler M Clin Rev Allergy Immunol; 2017 Apr; 52(2):202-216. PubMed ID: 27350273 [TBL] [Abstract][Full Text] [Related]
15. Clinical use of anti-DFS70 autoantibodies. Kang SY; Lee WI; Kim MH; La Jeon Y Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541 [TBL] [Abstract][Full Text] [Related]
16. Improved accuracy in DFS pattern interpretation using a novel HEp-2 ELITE system. Infantino M; Shovman O; Gilburd B; Manfredi M; Grossi V; Benucci M; Damiani A; Chimenti D; Malyavantham K; Shoenfeld Y Clin Rheumatol; 2019 May; 38(5):1293-1299. PubMed ID: 30617598 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD). Seelig CA; Bauer O; Seelig HP Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068 [TBL] [Abstract][Full Text] [Related]
18. New genetically engineered DFS70 knock-out HEp-2 cells enable rapid and specific recognition of anti-DFS70 antibodies. Bizzaro N; Fabris M Autoimmunity; 2018 Jun; 51(4):152-156. PubMed ID: 29732925 [TBL] [Abstract][Full Text] [Related]
19. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Mahler M; Fritzler MJ Clin Dev Immunol; 2012; 2012():494356. PubMed ID: 23304189 [TBL] [Abstract][Full Text] [Related]
20. Anti-DFS70 antibodies detected by immunoblot methods: A reliable tool to confirm the dense fine speckles ANA pattern. Bizzaro N; Pesente F; Cucchiaro F; Infantino M; Tampoia M; Villalta D; Fabris M; Tonutti E J Immunol Methods; 2016 Sep; 436():50-3. PubMed ID: 27374867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]